APO Research
Talk to an analyst

APO RESEARCH · REPORT

Histone Deacetylase 1

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Histone Deacetylase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

19 December 2025190 pages

Choose your research edition.

Industry ResearchHistone Deacetylase 1 Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Histone Deacetylase 1 Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Histone Deacetylase 1 Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Histone Deacetylase 1 Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Histone Deacetylase 1 Market Analysis and Forecast 2026-2032196 pages · $4,950 USD

Market perspective

The global Histone Deacetylase 1 market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Histone Deacetylase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Histone Deacetylase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Histone Deacetylase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Histone Deacetylase 1 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Histone Deacetylase 1 include 4SC AG, Acetylon Pharmaceuticals, Inc., Chipscreen Biosciences Ltd, Curis, Inc., HitGen LTD, IRBM Science Park SpA, Italfarmaco S.p.A., MEI Pharma, Inc. and Mirati Therapeutics Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Histone Deacetylase 1 market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Histone Deacetylase 1 and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Histone Deacetylase 1 sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Histone Deacetylase 1 market size, projected growth trends, production technologies, key applications, and end-use industries.

Histone Deacetylase 1 Segment by Company

4SC AG

Acetylon Pharmaceuticals, Inc.

Chipscreen Biosciences Ltd

Curis, Inc.

HitGen LTD

IRBM Science Park SpA

Italfarmaco S.p.A.

MEI Pharma, Inc.

Mirati Therapeutics Inc.

Oncolys BioPharma Inc.

Sigma-Tau S.p.A.

Syndax Pharmaceuticals, Inc.

TetraLogic Pharmaceuticals

GlaxoSmithKline Plc

Merck & Co., Inc.

Histone Deacetylase 1 Segment by Type

ST-3595

RCY-1305

HG-3001

CS-3158

ACY-957

Others

Histone Deacetylase 1 Segment by Application

Myelofibrosis

Skin Cancer

Neurology

Alopecia

Endometrial Cancer

Others

Histone Deacetylase 1 Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Histone Deacetylase 1 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Histone Deacetylase 1 and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Histone Deacetylase 1.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Histone Deacetylase 1 market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Histone Deacetylase 1 manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Histone Deacetylase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Histone Deacetylase 1 in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Histone Deacetylase 1 Industry Trends Table 2. Histone Deacetylase 1 Industry Drivers Table 3. Histone Deacetylase 1 Industry Opportunities and Challenges Table 4. Histone Deacetylase 1 Industry Restraints Table 5. Global Histone Deacetylase 1 Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Histone Deacetylase 1 Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Histone Deacetylase 1 Sales by Manufacturers (K Units) & (2021-2026) Table 8. Global Histone Deacetylase 1 Sales Market Share by Manufacturers Table 9. Global Histone Deacetylase 1 Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Histone Deacetylase 1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Histone Deacetylase 1 Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Histone Deacetylase 1 Manufacturers, Product Type & Application Table 13. Global Histone Deacetylase 1 Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Histone Deacetylase 1 by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of ST-3595 Table 17. Major Manufacturers of RCY-1305 Table 18. Major Manufacturers of HG-3001 Table 19. Major Manufacturers of CS-3158 Table 20. Major Manufacturers of ACY-957 Table 21. Major Manufacturers of Others Table 22. Global Histone Deacetylase 1 Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 23. Global Histone Deacetylase 1 Sales by Type (2021-2026) & (K Units) Table 24. Global Histone Deacetylase 1 Sales by Type (2027-2032) & (K Units) Table 25. Global Histone Deacetylase 1 Sales Market Share by Type (2021-2026) Table 26. Global Histone Deacetylase 1 Sales Market Share by Type (2027-2032) Table 27. Global Histone Deacetylase 1 Revenue by Type 2021 VS 2025 VS 2032 (K Units) Table 28. Global Histone Deacetylase 1 Revenue by Type (2021-2026) & (K Units) Table 29. Global Histone Deacetylase 1 Revenue by Type (2027-2032) & (K Units) Table 30. Global Histone Deacetylase 1 Revenue Market Share by Type (2021-2026) Table 31. Global Histone Deacetylase 1 Revenue Market Share by Type (2027-2032) Table 32. Major Manufacturers of Myelofibrosis Table 33. Major Manufacturers of Skin Cancer Table 34. Major Manufacturers of Neurology Table 35. Major Manufacturers of Alopecia Table 36. Major Manufacturers of Endometrial Cancer Table 37. Major Manufacturers of Others Table 38. Global Histone Deacetylase 1 Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 39. Global Histone Deacetylase 1 Sales by Application (2021-2026) & (K Units) Table 40. Global Histone Deacetylase 1 Sales by Application (2027-2032) & (K Units) Table 41. Global Histone Deacetylase 1 Sales Market Share by Application (2021-2026) Table 42. Global Histone Deacetylase 1 Sales Market Share by Application (2027-2032) Table 43. Global Histone Deacetylase 1 Revenue by Application 2021 VS 2025 VS 2032 (K Units) Table 44. Global Histone Deacetylase 1 Revenue by Application (2021-2026) & (K Units) Table 45. Global Histone Deacetylase 1 Revenue by Application (2027-2032) & (K Units) Table 46. Global Histone Deacetylase 1 Revenue Market Share by Application (2021-2026) Table 47. Global Histone Deacetylase 1 Revenue Market Share by Application (2027-2032) Table 48. Global Histone Deacetylase 1 Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 49. Global Histone Deacetylase 1 Sales by Region (2021-2026) & (K Units) Table 50. Global Histone Deacetylase 1 Sales Market Share by Region (2021-2026) Table 51. Global Histone Deacetylase 1 Sales Forecasted by Region (2027-2032) & (K Units) Table 52. Global Histone Deacetylase 1 Sales Forecasted Market Share by Region (2027-2032) Table 53. North America Histone Deacetylase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 54. North America Histone Deacetylase 1 Sales by Country (2021-2026) & (K Units) Table 55. North America Histone Deacetylase 1 Sales by Country (2027-2032) & (K Units) Table 56. Europe Histone Deacetylase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 57. Europe Histone Deacetylase 1 Sales by Country (2021-2026) & (K Units) Table 58. Europe Histone Deacetylase 1 Sales by Country (2027-2032) & (K Units) Table 59. Asia Pacific Histone Deacetylase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 60. Asia Pacific Histone Deacetylase 1 Sales by Country (2021-2026) & (K Units) Table 61. Asia Pacific Histone Deacetylase 1 Sales by Country (2027-2032) & (K Units) Table 62. South America, Middle East and Africa Histone Deacetylase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (K Units) Table 63. South America, Middle East and Africa Histone Deacetylase 1 Sales by Country (2021-2026) & (K Units) Table 64. South America, Middle East and Africa Histone Deacetylase 1 Sales by Country (2027-2032) & (K Units) Table 65. Global Histone Deacetylase 1 Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 66. Global Histone Deacetylase 1 Revenue by Region (2021-2026) & (US$ Million) Table 67. Global Histone Deacetylase 1 Revenue by Region (2027-2032) & (US$ Million) Table 68. Global Histone Deacetylase 1 Revenue Market Share by Region (2021-2026) Table 69. Global Histone Deacetylase 1 Revenue Market Share by Region (2027-2032) Table 70. 4SC AG Company Information Table 71. 4SC AG Business Overview Table 72. 4SC AG Histone Deacetylase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. 4SC AG Histone Deacetylase 1 Product Portfolio Table 74. 4SC AG Recent Development Table 75. Acetylon Pharmaceuticals, Inc. Company Information Table 76. Acetylon Pharmaceuticals, Inc. Business Overview Table 77. Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio Table 79. Acetylon Pharmaceuticals, Inc. Recent Development Table 80. Chipscreen Biosciences Ltd Company Information Table 81. Chipscreen Biosciences Ltd Business Overview Table 82. Chipscreen Biosciences Ltd Histone Deacetylase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Chipscreen Biosciences Ltd Histone Deacetylase 1 Product Portfolio Table 84. Chipscreen Biosciences Ltd Recent Development Table 85. Curis, Inc. Company Information Table 86. Curis, Inc. Business Overview Table 87. Curis, Inc. Histone Deacetylase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. Curis, Inc. Histone Deacetylase 1 Product Portfolio Table 89. Curis, Inc. Recent Development Table 90. HitGen LTD Company Information Table 91. HitGen LTD Business Overview Table 92. HitGen LTD Histone Deacetylase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. HitGen LTD Histone Deacetylase 1 Product Portfolio Table 94. HitGen LTD Recent Development Table 95. IRBM Science Park SpA Company Information Table 96. IRBM Science Park SpA Business Overview Table 97. IRBM Science Park SpA Histone Deacetylase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. IRBM Science Park SpA Histone Deacetylase 1 Product Portfolio Table 99. IRBM Science Park SpA Recent Development Table 100. Italfarmaco S.p.A. Company Information Table 101. Italfarmaco S.p.A. Business Overview Table 102. Italfarmaco S.p.A. Histone Deacetylase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Italfarmaco S.p.A. Histone Deacetylase 1 Product Portfolio Table 104. Italfarmaco S.p.A. Recent Development Table 105. MEI Pharma, Inc. Company Information Table 106. MEI Pharma, Inc. Business Overview Table 107. MEI Pharma, Inc. Histone Deacetylase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. MEI Pharma, Inc. Histone Deacetylase 1 Product Portfolio Table 109. MEI Pharma, Inc. Recent Development Table 110. Mirati Therapeutics Inc. Company Information Table 111. Mirati Therapeutics Inc. Business Overview Table 112. Mirati Therapeutics Inc. Histone Deacetylase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Mirati Therapeutics Inc. Histone Deacetylase 1 Product Portfolio Table 114. Mirati Therapeutics Inc. Recent Development Table 115. Oncolys BioPharma Inc. Company Information Table 116. Oncolys BioPharma Inc. Business Overview Table 117. Oncolys BioPharma Inc. Histone Deacetylase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Oncolys BioPharma Inc. Histone Deacetylase 1 Product Portfolio Table 119. Oncolys BioPharma Inc. Recent Development Table 120. Sigma-Tau S.p.A. Company Information Table 121. Sigma-Tau S.p.A. Business Overview Table 122. Sigma-Tau S.p.A. Histone Deacetylase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Sigma-Tau S.p.A. Histone Deacetylase 1 Product Portfolio Table 124. Sigma-Tau S.p.A. Recent Development Table 125. Syndax Pharmaceuticals, Inc. Company Information Table 126. Syndax Pharmaceuticals, Inc. Business Overview Table 127. Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio Table 129. Syndax Pharmaceuticals, Inc. Recent Development Table 130. TetraLogic Pharmaceuticals Company Information Table 131. TetraLogic Pharmaceuticals Business Overview Table 132. TetraLogic Pharmaceuticals Histone Deacetylase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. TetraLogic Pharmaceuticals Histone Deacetylase 1 Product Portfolio Table 134. TetraLogic Pharmaceuticals Recent Development Table 135. GlaxoSmithKline Plc Company Information Table 136. GlaxoSmithKline Plc Business Overview Table 137. GlaxoSmithKline Plc Histone Deacetylase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. GlaxoSmithKline Plc Histone Deacetylase 1 Product Portfolio Table 139. GlaxoSmithKline Plc Recent Development Table 140. Merck & Co., Inc. Company Information Table 141. Merck & Co., Inc. Business Overview Table 142. Merck & Co., Inc. Histone Deacetylase 1 Sales (K Units), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Merck & Co., Inc. Histone Deacetylase 1 Product Portfolio Table 144. Merck & Co., Inc. Recent Development Table 145. Key Raw Materials Table 146. Raw Materials Key Suppliers Table 147. Histone Deacetylase 1 Distributors List Table 148. Histone Deacetylase 1 Customers List Table 149. Research Programs/Design for This Report Table 150. Authors List of This Report Table 151. Secondary Sources Table 152. Primary Sources List of Figures Figure 1. Histone Deacetylase 1 Product Image Figure 2. Global Histone Deacetylase 1 Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Histone Deacetylase 1 Market Size (2021-2032) & (US$ Million) Figure 4. Global Histone Deacetylase 1 Sales (2021-2032) & (K Units) Figure 5. Global Histone Deacetylase 1 Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Histone Deacetylase 1 Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. ST-3595 Image Figure 9. RCY-1305 Image Figure 10. HG-3001 Image Figure 11. CS-3158 Image Figure 12. ACY-957 Image Figure 13. Others Image Figure 14. Global Histone Deacetylase 1 Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 15. Global Histone Deacetylase 1 Sales Market Share 2021 VS 2025 VS 2032 Figure 16. Global Histone Deacetylase 1 Sales Market Share by Type (2021-2032) Figure 17. Global Histone Deacetylase 1 Revenue by Type (2021 VS 2025 VS 2032) & (K Units) Figure 18. Global Histone Deacetylase 1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 19. Global Histone Deacetylase 1 Revenue Market Share by Type (2021-2032) Figure 20. Myelofibrosis Image Figure 21. Skin Cancer Image Figure 22. Neurology Image Figure 23. Alopecia Image Figure 24. Endometrial Cancer Image Figure 25. Others Image Figure 26. Global Histone Deacetylase 1 Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 27. Global Histone Deacetylase 1 Sales Market Share 2021 VS 2025 VS 2032 Figure 28. Global Histone Deacetylase 1 Sales Market Share by Application (2021-2032) Figure 29. Global Histone Deacetylase 1 Revenue by Application (2021 VS 2025 VS 2032) & (K Units) Figure 30. Global Histone Deacetylase 1 Revenue Market Share 2021 VS 2025 VS 2032 Figure 31. Global Histone Deacetylase 1 Revenue Market Share by Application (2021-2032) Figure 32. North America Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 33. North America Histone Deacetylase 1 Sales Market Share by Country (2021-2032) Figure 34. U.S. Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 35. Canada Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 36. Mexico Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 37. Europe Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 38. Europe Histone Deacetylase 1 Sales Market Share by Country (2021-2032) Figure 39. Germany Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 40. France Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 41. U.K. Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 42. Italy Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 43. Netherlands Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 44. Asia Pacific Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 45. Asia Pacific Histone Deacetylase 1 Sales Market Share by Country (2021-2032) Figure 46. China Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 47. Japan Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 48. South Korea Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 49. Southeast Asia Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 50. India Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 51. Australia Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 52. South America, Middle East and Africa Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 53. South America, Middle East and Africa Histone Deacetylase 1 Sales Market Share by Country (2021-2032) Figure 54. Brazil Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 55. South Africa Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 56. Saudi Arabia Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 57. Turkey Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 58. Argentina Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 59. UAE Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 60. Egypt Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 61. Chile Histone Deacetylase 1 Sales and Growth Rate (2021-2032) & (K Units) Figure 62. Global Histone Deacetylase 1 Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 63. Global Histone Deacetylase 1 Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 64. North America Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Figure 65. North America Histone Deacetylase 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 66. Europe Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Figure 67. Europe Histone Deacetylase 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 68. Asia-Pacific Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Figure 69. Asia-Pacific Histone Deacetylase 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 70. South America, Middle East and Africa Histone Deacetylase 1 Revenue (2021-2032) & (US$ Million) Figure 71. South America, Middle East and Africa Histone Deacetylase 1 Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 72. Histone Deacetylase 1 Value Chain Figure 73. Manufacturing Cost Structure Figure 74. Histone Deacetylase 1 Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Years Considered Figure 78. Research Process Figure 79. Key Executives Interviewed

Scope & coverage.

Types
  • ST-3595
  • RCY-1305
  • HG-3001
  • CS-3158
  • ACY-957
  • Others
Applications
  • Myelofibrosis
  • Skin Cancer
  • Neurology
  • Alopecia
  • Endometrial Cancer
  • Others
Companies covered
  • 4SC AG
  • Acetylon Pharmaceuticals, Inc.
  • Chipscreen Biosciences Ltd
  • Curis, Inc.
  • HitGen LTD
  • IRBM Science Park SpA
  • Italfarmaco S.p.A.
  • MEI Pharma, Inc.
  • Mirati Therapeutics Inc.
  • Oncolys BioPharma Inc.
  • Sigma-Tau S.p.A.
  • Syndax Pharmaceuticals, Inc.
  • TetraLogic Pharmaceuticals
  • GlaxoSmithKline Plc
  • Merck & Co., Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Histone Deacetylase 1 Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Histone Deacetylase 1 Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Histone Deacetylase 1 Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Histone Deacetylase 1 Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Histone Deacetylase 1 Market Dynamics
  1. 2.1 Histone Deacetylase 1 Industry Trends
  2. 2.2 Histone Deacetylase 1 Industry Drivers
  3. 2.3 Histone Deacetylase 1 Industry Opportunities and Challenges
  4. 2.4 Histone Deacetylase 1 Industry Restraints
3 Histone Deacetylase 1 Market by Manufacturers
  1. 3.1 Global Histone Deacetylase 1 Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Histone Deacetylase 1 Sales by Manufacturers (2021-2026)
  3. 3.3 Global Histone Deacetylase 1 Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Histone Deacetylase 1 Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Histone Deacetylase 1 Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Histone Deacetylase 1 Manufacturers, Product Type & Application
  7. 3.7 Global Histone Deacetylase 1 Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Histone Deacetylase 1 Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Histone Deacetylase 1 Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Histone Deacetylase 1 Tier 1, Tier 2, and Tier 3
4 Histone Deacetylase 1 Market by Type
  1. 4.1 Histone Deacetylase 1 Type Introduction
  2. 4.1.1 ST-3595
  3. 4.1.2 RCY-1305
  4. 4.1.3 HG-3001
  5. 4.1.4 CS-3158
  6. 4.1.5 ACY-957
  7. 4.1.6 Others
  8. 4.2 Global Histone Deacetylase 1 Sales by Type
  9. 4.2.1 Global Histone Deacetylase 1 Sales by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Histone Deacetylase 1 Sales by Type (2021-2032)
  11. 4.2.3 Global Histone Deacetylase 1 Sales Market Share by Type (2021-2032)
  12. 4.3 Global Histone Deacetylase 1 Revenue by Type
  13. 4.3.1 Global Histone Deacetylase 1 Revenue by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Histone Deacetylase 1 Revenue by Type (2021-2032)
  15. 4.3.3 Global Histone Deacetylase 1 Revenue Market Share by Type (2021-2032)
5 Histone Deacetylase 1 Market by Application
  1. 5.1 Histone Deacetylase 1 Application Introduction
  2. 5.1.1 Myelofibrosis
  3. 5.1.2 Skin Cancer
  4. 5.1.3 Neurology
  5. 5.1.4 Alopecia
  6. 5.1.5 Endometrial Cancer
  7. 5.1.6 Others
  8. 5.2 Global Histone Deacetylase 1 Sales by Application
  9. 5.2.1 Global Histone Deacetylase 1 Sales by Application (2021 VS 2025 VS 2032)
  10. 5.2.2 Global Histone Deacetylase 1 Sales by Application (2021-2032)
  11. 5.2.3 Global Histone Deacetylase 1 Sales Market Share by Application (2021-2032)
  12. 5.3 Global Histone Deacetylase 1 Revenue by Application
  13. 5.3.1 Global Histone Deacetylase 1 Revenue by Application (2021 VS 2025 VS 2032)
  14. 5.3.2 Global Histone Deacetylase 1 Revenue by Application (2021-2032)
  15. 5.3.3 Global Histone Deacetylase 1 Revenue Market Share by Application (2021-2032)
6 Global Histone Deacetylase 1 Sales by Region
  1. 6.1 Global Histone Deacetylase 1 Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Histone Deacetylase 1 Sales by Region (2021-2032)
  3. 6.2.1 Global Histone Deacetylase 1 Sales by Region (2021-2026)
  4. 6.2.2 Global Histone Deacetylase 1 Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Histone Deacetylase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Histone Deacetylase 1 Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Histone Deacetylase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Histone Deacetylase 1 Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Histone Deacetylase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Histone Deacetylase 1 Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Histone Deacetylase 1 Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Histone Deacetylase 1 Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Histone Deacetylase 1 Revenue by Region
  1. 7.1 Global Histone Deacetylase 1 Revenue by Region
  2. 7.1.1 Global Histone Deacetylase 1 Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Histone Deacetylase 1 Revenue by Region (2021-2026)
  4. 7.1.3 Global Histone Deacetylase 1 Revenue by Region (2027-2032)
  5. 7.1.4 Global Histone Deacetylase 1 Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Histone Deacetylase 1 Revenue (2021-2032)
  8. 7.2.2 North America Histone Deacetylase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Histone Deacetylase 1 Revenue (2021-2032)
  11. 7.3.2 Europe Histone Deacetylase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Histone Deacetylase 1 Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Histone Deacetylase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Histone Deacetylase 1 Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Histone Deacetylase 1 Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 4SC AG
  2. 8.1.1 4SC AG Company Information
  3. 8.1.2 4SC AG Business Overview
  4. 8.1.3 4SC AG Histone Deacetylase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 4SC AG Histone Deacetylase 1 Product Portfolio
  6. 8.1.5 4SC AG Recent Developments
  7. 8.2 Acetylon Pharmaceuticals, Inc.
  8. 8.2.1 Acetylon Pharmaceuticals, Inc. Company Information
  9. 8.2.2 Acetylon Pharmaceuticals, Inc. Business Overview
  10. 8.2.3 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Acetylon Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio
  12. 8.2.5 Acetylon Pharmaceuticals, Inc. Recent Developments
  13. 8.3 Chipscreen Biosciences Ltd
  14. 8.3.1 Chipscreen Biosciences Ltd Company Information
  15. 8.3.2 Chipscreen Biosciences Ltd Business Overview
  16. 8.3.3 Chipscreen Biosciences Ltd Histone Deacetylase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Chipscreen Biosciences Ltd Histone Deacetylase 1 Product Portfolio
  18. 8.3.5 Chipscreen Biosciences Ltd Recent Developments
  19. 8.4 Curis, Inc.
  20. 8.4.1 Curis, Inc. Company Information
  21. 8.4.2 Curis, Inc. Business Overview
  22. 8.4.3 Curis, Inc. Histone Deacetylase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Curis, Inc. Histone Deacetylase 1 Product Portfolio
  24. 8.4.5 Curis, Inc. Recent Developments
  25. 8.5 HitGen LTD
  26. 8.5.1 HitGen LTD Company Information
  27. 8.5.2 HitGen LTD Business Overview
  28. 8.5.3 HitGen LTD Histone Deacetylase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 HitGen LTD Histone Deacetylase 1 Product Portfolio
  30. 8.5.5 HitGen LTD Recent Developments
  31. 8.6 IRBM Science Park SpA
  32. 8.6.1 IRBM Science Park SpA Company Information
  33. 8.6.2 IRBM Science Park SpA Business Overview
  34. 8.6.3 IRBM Science Park SpA Histone Deacetylase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 IRBM Science Park SpA Histone Deacetylase 1 Product Portfolio
  36. 8.6.5 IRBM Science Park SpA Recent Developments
  37. 8.7 Italfarmaco S.p.A.
  38. 8.7.1 Italfarmaco S.p.A. Company Information
  39. 8.7.2 Italfarmaco S.p.A. Business Overview
  40. 8.7.3 Italfarmaco S.p.A. Histone Deacetylase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Italfarmaco S.p.A. Histone Deacetylase 1 Product Portfolio
  42. 8.7.5 Italfarmaco S.p.A. Recent Developments
  43. 8.8 MEI Pharma, Inc.
  44. 8.8.1 MEI Pharma, Inc. Company Information
  45. 8.8.2 MEI Pharma, Inc. Business Overview
  46. 8.8.3 MEI Pharma, Inc. Histone Deacetylase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 MEI Pharma, Inc. Histone Deacetylase 1 Product Portfolio
  48. 8.8.5 MEI Pharma, Inc. Recent Developments
  49. 8.9 Mirati Therapeutics Inc.
  50. 8.9.1 Mirati Therapeutics Inc. Company Information
  51. 8.9.2 Mirati Therapeutics Inc. Business Overview
  52. 8.9.3 Mirati Therapeutics Inc. Histone Deacetylase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Mirati Therapeutics Inc. Histone Deacetylase 1 Product Portfolio
  54. 8.9.5 Mirati Therapeutics Inc. Recent Developments
  55. 8.10 Oncolys BioPharma Inc.
  56. 8.10.1 Oncolys BioPharma Inc. Company Information
  57. 8.10.2 Oncolys BioPharma Inc. Business Overview
  58. 8.10.3 Oncolys BioPharma Inc. Histone Deacetylase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Oncolys BioPharma Inc. Histone Deacetylase 1 Product Portfolio
  60. 8.10.5 Oncolys BioPharma Inc. Recent Developments
  61. 8.11 Sigma-Tau S.p.A.
  62. 8.11.1 Sigma-Tau S.p.A. Company Information
  63. 8.11.2 Sigma-Tau S.p.A. Business Overview
  64. 8.11.3 Sigma-Tau S.p.A. Histone Deacetylase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Sigma-Tau S.p.A. Histone Deacetylase 1 Product Portfolio
  66. 8.11.5 Sigma-Tau S.p.A. Recent Developments
  67. 8.12 Syndax Pharmaceuticals, Inc.
  68. 8.12.1 Syndax Pharmaceuticals, Inc. Company Information
  69. 8.12.2 Syndax Pharmaceuticals, Inc. Business Overview
  70. 8.12.3 Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Syndax Pharmaceuticals, Inc. Histone Deacetylase 1 Product Portfolio
  72. 8.12.5 Syndax Pharmaceuticals, Inc. Recent Developments
  73. 8.13 TetraLogic Pharmaceuticals
  74. 8.13.1 TetraLogic Pharmaceuticals Company Information
  75. 8.13.2 TetraLogic Pharmaceuticals Business Overview
  76. 8.13.3 TetraLogic Pharmaceuticals Histone Deacetylase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 TetraLogic Pharmaceuticals Histone Deacetylase 1 Product Portfolio
  78. 8.13.5 TetraLogic Pharmaceuticals Recent Developments
  79. 8.14 GlaxoSmithKline Plc
  80. 8.14.1 GlaxoSmithKline Plc Company Information
  81. 8.14.2 GlaxoSmithKline Plc Business Overview
  82. 8.14.3 GlaxoSmithKline Plc Histone Deacetylase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 GlaxoSmithKline Plc Histone Deacetylase 1 Product Portfolio
  84. 8.14.5 GlaxoSmithKline Plc Recent Developments
  85. 8.15 Merck & Co., Inc.
  86. 8.15.1 Merck & Co., Inc. Company Information
  87. 8.15.2 Merck & Co., Inc. Business Overview
  88. 8.15.3 Merck & Co., Inc. Histone Deacetylase 1 Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Merck & Co., Inc. Histone Deacetylase 1 Product Portfolio
  90. 8.15.5 Merck & Co., Inc. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Histone Deacetylase 1 Value Chain Analysis
  2. 9.1.1 Histone Deacetylase 1 Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Histone Deacetylase 1 Production Mode & Process
  6. 9.2 Histone Deacetylase 1 Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Histone Deacetylase 1 Distributors
  9. 9.2.3 Histone Deacetylase 1 Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst